Inventor · disambiguated record
Allen Radin
Also filed as: RADIN ALLEN
23 granted patents·20 pending applications·268 citations·filing 2005–2023
96Inventor score
Files withREGENERON PHARMA22SANOFI BIOTECHNOLOGY13RADIN ALLEN4REGENERAN PHARMACEUTICALS INC2SANOFI SA1
Top patents by PatentIndex Score
43 records- 0195US10485844B2Methods for treating severe atopic dermatitis by administering an IL-4R inhibitorREGENERON PHARMA·Filed 2017·Granted Nov 26, 2019·26 cites·57 claims
- 0294US10066017B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2015·Granted Sep 4, 2018·25 cites·33 claims
- 0394US8192741B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyRADIN ALLEN·Filed 2011·Granted Jun 5, 2012·22 cites·10 claims
- 0493US10730948B2Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitorREGENERON PHARMA·Filed 2016·Granted Aug 4, 2020·16 cites·20 claims
- 0593US10059771B2Methods for treating nasal polyposis by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2014·Granted Aug 28, 2018·26 cites·57 claims
- 0693US9574004B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI SA·Filed 2013·Granted Feb 21, 2017·44 cites·19 claims
- 0793US8568721B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyRADIN ALLEN·Filed 2012·Granted Oct 29, 2013·18 cites·9 claims
- 0892US10370449B2Methods for treating skin infection by administering an IL-4R antagonistREGENERON PHARMA·Filed 2015·Granted Aug 6, 2019·16 cites·21 claims
- 0991US11421036B2Methods of treating eosinophilic esophagitis by administering an antibody which inhibits interleukin-4 receptor (IL-4R)REGENERON PHARMA·Filed 2020·Granted Aug 23, 2022·2 cites·16 claims
- 1091US11053309B2Methods for treating active eosinophilic esophagitisREGENERON PHARMA·Filed 2018·Granted Jul 6, 2021·12 cites·22 claims
- 1191US9308256B2Method of treating rheumatoid arthritis with an anti-IL-6R antibodyREGENERON PHARMA·Filed 2013·Granted Apr 12, 2016·11 cites·14 claims
- 1291US8080248B2Method of treating rheumatoid arthritis with an IL-6R antibodyRADIN ALLEN·Filed 2010·Granted Dec 20, 2011·15 cites·11 claims
- 1388US11167004B2Methods for treating severe atopic dermatitis by administering an IL-4R inhibitorREGENERAN PHARMACEUTICALS INC·Filed 2019·Granted Nov 9, 2021·4 cites·20 claims
- 1487US11845800B2Methods for treating or preventing asthma by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2017·Granted Dec 19, 2023·4 cites·33 claims
- 1587US10927435B2Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2012·Granted Feb 23, 2021·8 cites·18 claims
- 1686US9943594B2Methods for the treatment of rheumatoid arthritisSANOFI BIOTECHNOLOGY·Filed 2012·Granted Apr 17, 2018·8 cites·13 claims
- 1785US7361350B2Use of an IL-1 antagonist for treating arthritisREGENERON PHARMA·Filed 2005·Granted Apr 22, 2008·6 cites·9 claims
- 1884US11352417B2Method of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2017·Granted Jun 7, 2022·2 cites·9 claims
- 1984US11214621B2Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Granted Jan 4, 2022·2 cites·39 claims
- 2080US2024199751A1Methods for treating or preventing asthma by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 2179US12291571B2Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibodyREGENERON PHARMA·Filed 2022·Granted May 6, 2025·0 cites·27 claims
- 2277US11504426B2Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonistREGENERON PHARMA·Filed 2020·Granted Nov 22, 2022·1 cites·28 claims
- 2374US2023357416A1Methods for treating skin infection by administering an il-4r antagonistREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2473US12502429B2Methods for treating atopic dermatitis by administering an IL-4R antagonistREGENERON PHARMA·Filed 2022·Granted Dec 23, 2025·0 cites·42 claims
- 2571US11603408B2Methods for treating skin infection by administering an IL-4R antagonistREGENERAN PHARMACEUTICALS INC·Filed 2019·Granted Mar 14, 2023·0 cites·17 claims
- 2670US2024092882A1Method of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 2769US2022204631A1Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 2869US2023203141A1Methods of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 2963US2021363237A1Methods for treating active eosinophilic esophagitisREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 3062US2023293682A1Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an il-4r antagonistREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 3161US2021230719A1Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2020·Application pending·0 cites
- 3261US2022064270A1Method of treating an allergy with allergen-specific monoclonal antibodiesREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 3357US2023146317A1Methods for treating chronic spontaneous urticaria by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 3456US2024034798A1Methods for treating eosinophilic esophagitis by administering an il-4r antagonistREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 3555US2022110999A1Methods for treating severe atopic dermatitis by administering an il-4r inhibitorREGENERON PHARMA·Filed 2021·Application pending·0 cites
- 3653US2018296670A1Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2018·Application pending·0 cites
- 3752US2014072583A1Methods for treating atopic dermatitis by administering an il-4r antagonistREGENERON PHARMA·Filed 2013·Application pending·0 cites
- 3852US2022220211A1Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonistREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 3950US2019040146A1Methods for treating nasal polyposis by administering an il-4r antagonistSANOFI BIOTECHNOLOGY·Filed 2018·Application pending·0 cites
- 4049US2017333557A1Methods for Treating Atopic Dermatitis by Administering an IL-4R AntagonistREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 4148US2006160737A1Methods of using IL-1 antagonists to treat polymyalgia rheumatica and giant cell arteritisRADIN ALLEN·Filed 2006·Application pending·0 cites
- 4248US2006171948A1Methods of using IL-1 antagonists to reduce C-reactive proteinWEINSTEIN STEVEN P·Filed 2006·Application pending·0 cites
- 4338US2016280782A1Compositions for the treatment of rheumatoid arthritis and methods of using sameSANOFI BIOTECHNOLOGY·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allen Radin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →